Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:07 2024-05-03 pm EDT 5-day change 1st Jan Change
72.86 USD +1.15% Intraday chart for Boston Scientific Corporation -0.42% +26.03%
Sales 2024 * 15.98B Sales 2025 * 17.55B Capitalization 107B
Net income 2024 * 2.19B Net income 2025 * 2.72B EV / Sales 2024 * 7.08 x
Net Debt 2024 * 6.01B Net Debt 2025 * 3.57B EV / Sales 2025 * 6.3 x
P/E ratio 2024 *
49.7 x
P/E ratio 2025 *
40.3 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.15%
1 week-0.42%
Current month+1.38%
1 month+7.54%
3 months+13.19%
6 months+38.70%
Current year+26.03%
More quotes
1 week
70.97
Extreme 70.97
73.13
1 month
66.80
Extreme 66.8
74.39
Current year
57.11
Extreme 57.11
74.39
1 year
48.35
Extreme 48.35
74.39
3 years
34.98
Extreme 34.98
74.39
5 years
24.10
Extreme 24.1
74.39
10 years
11.10
Extreme 11.1
74.39
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 71 16-07-12
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
More insiders
Date Price Change Volume
24-05-03 72.85 +1.14% 7,452,084
24-05-02 72.03 -0.25% 7,610,487
24-05-01 72.21 +0.47% 6,021,096
24-04-30 71.87 -0.87% 8,718,137
24-04-29 72.5 -0.92% 9,463,878

Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
72.85 USD
Average target price
81 USD
Spread / Average Target
+11.18%
Consensus